拉米夫定被批准临床应用以来,进入一个核苷(酸)类似物治疗慢性乙型肝炎的新时代。临床上有了直接抗乙型肝炎病毒的治疗方法,并有了对不能取得持续应答的患者实施长期抗病毒治疗的可能性,使通过抗病毒药物维持治疗达到维持应答以保证患者长期病情稳定、阻止病情进展成为现实。近 Lamivudine has been approved for clinical use to enter a new era of nucleoside (acid) analogs for the treatment of chronic hepatitis B. Clinically, there is a direct anti-hepatitis B virus treatment and there is the possibility of long-term antiviral treatment of patients who can not achieve sustained response so as to maintain response through maintenance treatment of antiviral drugs so as to ensure long-term patient’s stable condition, Stop the progress of the disease a reality. near